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ABSTRACT
Development of alternatively activated (M2) macrophage
phenotypes is a complex process that is coordinately
regulated by a plethora of pathways and factors. Here,
we report that RBP-J, a DNA-binding protein that inte-
grates signals from multiple pathways including the
Notch pathway, is critically involved in polarization of M2
macrophages. Mice deﬁcient in RBP-J in the myeloid
compartment exhibited impaired M2 phenotypes in vivo
in a chitin-induced model of M2 polarization. Consistent
with the in vivo ﬁndings, M2 polarization was partially
compromised in vitro in Rbpj-deﬁcient macrophages as
demonstrated by reduced expression of a subset of M2
effector molecules including arginase 1. Functionally,
myeloid Rbpj deﬁciency impaired M2 effector functions
including recruitment of eosinophils and suppression of
T cell proliferation. Collectively, we have identiﬁed RBP-
J as an essential regulator of differentiation and function
of alternatively activated macrophages.
KEYWORDS macrophages, RBP-J, M2, arginase,
chitin
INTRODUCTION
Macrophages are versatile cells with diverse functions in
inﬂammation, tissue remodeling, angiogenesis, and tumor
immunity. They respond to a wide variety of environmental
cues to regulate immunity and inﬂammation by sensing
microbial pathogens, secreting cytokines and inﬂammatory
mediators, and presenting antigens to T cells. Depending on
environmental signals, macrophages can display a spectrum
of activation states ranging from classically activated, M1
inﬂammatory macrophages, to various alternatively acti-
vated M2 macrophages that are involved in immune regu-
lation and tissue repair (Murray and Wynn, 2011; Ivashkiv,
2013). M1 macrophages are characterized by production of
high levels of inﬂammatory mediators in response to stimu-
lation by pathogen-associated molecular patterns and/or
inﬂammatory cytokines. In contrast, M2 macrophages
express less inﬂammatory mediators and play a key role in
wound healing and resolution of inﬂammation (Mosser and
Edwards, 2008; Murray et al., 2014). One mechanism by
which M2 macrophages limit inﬂammation and restore
homeostasis is suppression of T cell proliferation, which is
mediated at least in part by a key M2 effector molecule
arginase 1 (Arg1) (Chawla et al., 2011). Besides their sup-
pressive functions, M2 macrophages are also involved in
host defense against helminthes by recruiting eosinophils to
the sites of infection. M2 polarization is driven by products of
mast cells, TH2 cells, and basophils including IL-4 that sig-
nals through the Jak-STAT signaling pathway to activate the
latent transcription factor STAT6 (Chawla et al., 2011). IL-4-
signaling promotes M2 polarization by upregulating expres-
sion of genes including those encoding Arg1, mannose
receptor (MR), and Ym1, hallmarks of M2 phenotypes. In
addition to IL-4-STAT6, a number of pathways and tran-
scription factors such as PPARγ and IRF4 are also critically
involved in driving M2 polarization (Odegaard et al., 2007;
Satoh et al., 2010).
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Recombinant recognition sequence binding protein at the
Jκ site (RBP-J, also named CSL or CBF1) is the central
nuclear mediator of canonical Notch signaling whose acti-
vation leads to transcription of Notch target genes. The
evolutionarily conserved Notch signaling pathway regulates
cell proliferation, apoptosis, and cell fate decisions during
development and adult tissue homeostasis (Kopan and Ila-
gan, 2009). Recent studies using global expression analysis
and chromatin immunoprecipitation deep-sequencing (ChIP-
seq) have revealed genome-wide Notch-RBP-J targets in
various systems including hematopoiesis (Hamidi et al.,
2011), neural stem cell differentiation (Li et al., 2012),
Epstein-Barr virus infection (Zhao et al., 2011), and
T-lymhoblastic leukemia/lymphoma (Palomero et al., 2006;
Wang et al., 2011). In the immune system, the most estab-
lished functions for Notch signaling is regulation of devel-
opment of lymphoid T and B cell lineages (Radtke et al.,
2010; Yuan et al., 2010). Less well characterized, however,
is the role of Notch signaling in myeloid cell differentiation
and function. Notch-RBP-J signaling has been shown to
control development and differentiation of multiple myeloid
lineages including granulocyte/monocyte progenitors, den-
dritic cells, and osteoclasts (Klinakis et al., 2011; Lewis et al.,
2011; Zhao et al., 2012). Although Notch signaling is not
required for normal development of macrophage populations
under homeostatic conditions, recently mounting evidence
suggests that Notch signaling has profound effects on
macrophage activation and polarization. Constitutive
expression of Notch pathway components and constitutive
activities of Notch signaling have been detected on macro-
phages of both human and mouse origin (Monsalve et al.,
2006; Fung et al., 2007; Hu et al., 2008; Zhang et al., 2010).
Notch signaling in macrophage regulates expression of pro-
and anti-inﬂammatory mediators in response to macrophage
activating signals such as LPS (Hu et al., 2008; Zhang et al.,
2010; Zhang et al., 2012; Monsalve et al., 2009; Palaga
et al., 2008; Tsao et al., 2011; Outtz et al. 2010). Moreover,
we and others have shown that Notch-RBP-J is required for
induction of a restricted subset of inﬂammatory M1 genes
that includes Il12b (encodes p40 subunit shared by IL-12
and IL-23) and Nos2 (encodes iNOS). Thus, RBP-J pro-
motes inﬂammatory M1 macrophage polarization in a
focused manner that is important for processes such as anti-
tumor responses and host defense against intracellular
bacteria (Wang et al., 2010; Xu et al., 2012).
However, little is known about the role of the Notch-RBP-J
pathway in M2 macrophages. As the M1 and M2 phenotypes
are on extreme ends of the macrophage polarization spec-
trum and can oppose each other, we hypothesized that M2
responses may be augmented in RBP-J-deﬁcient macro-
phages, which was supported by initial results that the M2-
promoting factor JmjD3 is superinduced after TLR stimula-
tion of RBP-J-deﬁcient cells (Xu et al., 2012). In this study,
we investigated the involvement of RBP-J in M2 macro-
phage polarization. Surprisingly, we found that RBP-J is
critically involved in M2 polarization and function in vivo and
in vitro, and regulates a restricted subset of key M2 effector
molecules such as Arg1. Thus, RBP-J is the ﬁrst transcrip-
tion factor described to play a role in expression of tran-
scriptional modules that are components of M1 and M2
phenotypes. This suggests that RBP-J may contribute to the
complex ‘mixed’ M1-M2 phenotype that has been described
in vivo. In addition, the common function of iNOS and Arg1 in
suppressing Tcell proliferation suggests an important role for
RBP-J in restricting T cell proliferation in various settings of
macrophage polarization.
RESULTS
RBP-J promotes M2 macrophage function in vivo
The Notch signaling pathway and RBP-J are generally
thought to play a positive role in promoting classical M1
macrophage polarization (Wang et al., 2010; Xu et al., 2012).
To investigate the functional roles of the Notch pathway in
alternatively activated macrophage polarization, we gener-
ated mice conditionally deﬁcient in Rbpj in their myeloid
compartments (Rbpj cKO) by crossing Rbpjﬂox/ﬂox animals to
animals with a Lyz2-Cre as described previously (Hu et al.,
2008). We then subjected Rbpj cKO mice and wildtype (WT)
littermate control animals to an in vivo model of chitin-in-
duced M2 polarization. Chitin is an N-acetyl-β-D-glu-
cosamine polysaccharide and a major structural component
of helminthes, fungi, and anthropods. It has been previously
shown that intraperitoneal administration of chitin recruits
macrophages with the M2 phenotype to the peritoneal cavity,
which are important for the subsequent recruitment of eosi-
nophils (Satoh et al., 2010; Reese et al., 2007). One day
after intraperitoneal administration of chitin, we found that
the total number of peritoneal exudate cells (PECs) did not
signiﬁcantly differ between WT control and RBP-J-deﬁcient
animals (data not shown). Next, we examined populations of
macrophages in PECs by ﬂow cytometry. Consistent with
previous reports, CD11b+F4/80+ macrophages were present
in the PECs from WT mice (Fig. 1A). Furthermore, the per-
centage of CD11b+F4/80+ macrophages in PECs was
comparable between WT and Rbpj cKO mice after chitin
administration (one representative experiment shown in
Fig. 1A and cumulative data from three independent exper-
iments shown in Fig. 1B), suggesting that Rbpj deﬁciency did
not signiﬁcantly alter the total macrophage population in
response to an M2 stimulus in vivo. Next, we used a well
established in vivo model of chitin-induced functional polar-
ization of M2 macrophages, where an important M2 function
is recruitment of eosinophils to the sites of inﬂammation
(Satoh et al., 2010; Reese et al., 2007). As measured by
percentage of CD45+SiglecF+ cells as previously described
(Satoh et al., 2010), chitin-induced recruitment of eosinophils
was signiﬁcantly reduced in Rbpj cKO mice compared with
WT controls (one representative experiment shown in
Fig. 1C and cumulative data from 6 pairs of mice shown in
Fig. 1D), suggesting that Rbpj deﬁciency in the myeloid
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lineage impairs M2 macrophage function. Taken together, in
the model of chitin-induced M2 polarization, recruitment of
macrophages to peritoneal cavity does not require RBP-J,
but RBP-J is indispensable for optimal functional polarization
of M2 macrophages in vivo.
RBP-J promotes M2 polarization in vivo
Next, we wished to investigate the mechanisms underlying
promotion of M2 function by RBP-J and examined pheno-
types of chitin-elicited macrophages. A previous report has
demonstrated that after chitin injection, classical M2 markers
including arginase 1 (Arg1), mannose receptor (MR), and
Ym1 are mainly expressed in macrophages but not in other
PECs such as B cells or eosinophils (Satoh et al., 2010).
Therefore, we assessed expression of M2 macrophage-as-
sociated genes in chitin-elicited PECs and found that
expression of genes encoding Arg1 and MR was signiﬁ-
cantly lower in PECs isolated from Rbpj cKO mice compared
with WT controls (Fig. 2A). In addition, expression of mRNA
encoding another M2 marker, Ym1, also showed a trend
towards decreased expression in Rbpj cKO mice (Fig. 2A),
suggesting that Rbpj deﬁciency in the myeloid cells leads to
impaired M2 polarization in vivo as manifested by reduced
expression of a subset of M2-associated genes. However,
RBP-J deﬁciency did not result in a global defect in M2 gene
program as expression of Marco and Jmjd3, two prototypical
M2-associated genes was not reduced in Rbpj cKO mice
(Fig. 2B), indicating a restricted effect on M2 phenotype that
is similar to the restricted effects of RBP-J deﬁciency on the
M1 phenotype (Xu et al., 2012). In addition, the expression of
an M1 macrophage-associated gene encoding IL-12p40
subunit was unchanged after chitin administration (Fig. 2C).
Of note, we and others have shown that IL-12p40 upregu-
lation following LPS treatment is attenuated in Rbpj-deﬁcient
bone-marrow derived macrophages (BMDMs) (Wang et al.,
2010; Xu et al., 2012). Our results shown here are not in
contradiction with previously published results regarding
regulation of IL-12p40 expression because chitin adminis-














































































Figure 1. A role for Rbpj in eosinophil recruitment in response to chitin administration. (A) Expression of CD11b and F4/80 in
peritoneal exudates cells (PECs) harvested from WTand Rbpj cKO mice 1 d after peritoneal injection with chitin. Circles and numbers
indicate percentage of macrophages (CD11b+F4/80+) in total PECs. Results from one representative experiment are shown.
(B) Cumulative data showing percentage of macrophages as in (A) from three independent experiments. (C) Expression of CD45 and
SiglecF in PECs harvested from WT and Rbpj cKO mice 1 d after peritoneal injection with chitin. Quadrants and numbers indicate
percentage of eosinophils (CD45+SiglecF+) in total PECs. (D) Cumulative data showing percentage of eosinophils as in (C) using six
pairs of littermate mice with desired genotypes. Errors bars indicate s.d. *P < 0.05 (two-tailed Student’s t-test).
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PECs and IL-12p40 levels remain near baseline and low
compared to the expression of the M2 genes encoding Arg1
and MR (data not shown). These results show that RBP-J is
required for development of macrophages that express Arg1
in vivo in the chitin-induced model of M2 polarization.
RBP-J is required for M2-mediated suppression of Tcell
proliferation
One important function of M2 macrophages is the suppres-
sion of T cell proliferation and expression of Arg1 is thought
to be critical for M2-mediated suppression of T cells (Pesce
et al., 2009). As RBP-J promotes expression of M2-associ-
ated genes including Arg1, we hypothesized that RBP-J may
be involved in inhibition of T cell responses by M2 macro-
phages and assessed the role of RBP-J in mediating this M2
function both ex vivo and in vitro. For ex vivo experiments,
we co-cultured PECs isolated from Rbpj cKO mice and lit-
termate control mice following intraperitoneal chitin admin-
istration with CFSE-labeled OT-II transgenic lymph node
(LN) cells in the presence of cognate OVA peptide. Con-
sistent with previous reports (Pesce et al., 2009), we found
that compared to PECs isolated from PBS-injected WT mice,
chitin-elicited PECs severely inhibited CD4+ T cell prolifera-
tion in response to OVA (Fig. 3A, ﬁlled gray histogram versus
black line), demonstrating a potent suppressive function of
chitin-polarized M2 macrophages. However, when chitin-
elicited PECs from Rbpj cKO mice were used in the co-
culture, CD4+ T cell proliferation was comparable to that
mediated by control, PBS-treated, PECs (Fig. 3A, gray line),
implicating a loss of suppressive function in Rbpj-deﬁcient
cells and thus suggesting that RBP-J plays a crucial role in
the inhibition of T cell proliferation by chitin-elicited PECs. To
conﬁrm this result, we turned to an in vitro system of T cell
suppression and used BMDMs isolated from Rbpj cKO and
WT littermate control mice cultured in the presence of
M-CSF either with or without IL-4 for 24 h to induce alter-
native activation before the addition of CFSE-labeled LN
cells. Similar to our results with ex vivo PECs, we found that
WT BMDMs treated with IL-4 strongly inhibited CD4+ T cell
proliferation as compared to BMDMs cultured without IL-4
(Fig. 3B, left panel). This inhibition was attenuated when
Rbpj-deﬁcient BMDMs were used in the co-cultures (Fig. 3B,






















































































































































Figure 2. Crucial role for Rbpj in regulating M2 macrophage polarization in response to chitin administration in vivo. Total
mRNA was prepared from PECs isolated from WT and Rbpj cKO mice 24 h after administration of chitin, and mRNA expression
of Arg1, MR, Ym1, Marco, Jmjd3, and IL-12p40 (relative to GAPDH mRNA) was measured using quantitative real-time PCR.
****P < 0.0001 (two-tailed Student’s t-test). *P < 0.05 (two-tailed Student’s t-test). Results are representative of four independent
experiments, each with two-four pairs of littermate mice (analyzed individually).
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promotes M2 suppressive functions including inhibition of T
cell proliferation, likely through regulation of expression of
M2 effector molecules such as Arg1.
RBP-J promotes expression of M2-associated
molecules
As we observed a requirement for RBP-J in maintaining high
levels of M2-asscoiated genes in vivo in chitin-elicited PECs
(Fig. 2A), we wished to further characterize RBP-J-mediated
regulation of M2 genes. We utilized the in vitro system of
M-CSF-differentiated BMDMs from Rbpj cKO and littermate
control mice and treated the cells with IL-4 after 5 days of
M-CSF-induced differentiation to induce M2 macrophage
polarization. As expected, Arg1 protein and mRNA expres-
sion was induced by IL-4 in a time-dependent manner in
control WT macrophages (Fig. 4A and 4B). Interestingly,
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Figure 3. Rbpj-deﬁcient alternatively activated macrophages are defective in suppressing T cell proliferation. (A) PECs from
control, PBS-injected WT mice (ﬁlled gray histogram), and day-1 chitin-elicited PECs from WT mice (black line) and Rbpj cKO (grey
line) were co-cultured with CFSE-labeled LN cells from OT-II transgenic mice and cognate OVA peptide. Proliferation of CD4+ cells
was examined at 96 h of co-culture. Results are representative of three independent experiments. (B) CFSE-labeled OT-II transgenic
LN cells were co-cultured with control (ﬁlled gray histogram) or IL-4-treated (10 ng/mL, black line) BMDMs from WTor Rbpj cKO mice























































Figure 4. A crucial role for Rbpj in regulating expression of a subset of M2 macrophage genes. BMDMs from WT and Rbpj
cKO mice were stimulated with IL-4 (10 ng/mL) for the indicated times. (A) Immunoblot analysis of whole cell lysates using antibodies
recognizing Arg1. Levels of SHP2 served as loading controls. Results are representative of three independent experiments. (B and C)
mRNA expression (relative to GAPDH mRNA) was measured using quantitative real-time PCR. Cumulative results from three
independent experiments are shown (errors bars indicate s.d.). P < 0.05, **P < 0.01 (two-tailed Student’s t-test).
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protein and mRNA than BMDMs isolated from littermate
controls prior to IL-4 treatment (Fig. 4A and 4B, 0 h time
points). Nevertheless, Rbpj-deﬁcient BMDMs were able to
upregulate Arg1 mRNA and protein expression in response
to IL-4 stimulation (Fig. 4A and 4B, lanes 6–10). However,
due to the drastically reduced baseline expression, Arg1
expression was still markedly lower post IL-4 stimulation in
Rbpj-deﬁcient cells compared with Arg1 levels in control
macrophages (Fig. 4A and 4B). These results implicate that
RBP-J plays an essential role in maintaining baseline
expression of Arg1 in macrophages but is dispensable for its
IL-4-induced upregulation. In contrast, baseline mRNA
expression of Ym1 was similar between WT and Rbpj-deﬁ-
cient BMDMs; however, IL-4-induced upregulation was
attenuated in the absence of Rbpj (Fig. 4C). Taken together,
our results indicate that RBP-J regulates expression of M2-
associated molecules by either maintaining their basal levels
in macrophages or promoting gene induction in response to
M2-polarizing factors such as IL-4.
As Arg1 is a key M2 effector molecule whose basal
expression is largely dependent on RBP-J in macrophages,
we wished to further elucidate the mechanisms by which
RBP-J regulates Arg1 expression. It has been previously
established that the Arg1 gene expression is controlled by
several transcription factors such as STAT6 and CAAT/en-
hancer binding protein-β (C/EBPβ) (Chawla et al., 2011; El
Kasmi et al., 2008). Therefore, we examined activation and
expression of these transcription factors in Rbpj-deﬁcient
and control macrophages. We found that activation of STAT6
as assessed by its tyrosine phosphorylation was similar in
WT and Rbpj-deﬁcient macrophages after IL-4 treatment
(Fig. 5A), showing that IL-4-induced STAT6 signaling
remains intact in the absence of RBP-J. This result is con-
sistent with the observation that IL-4-inducible Arg1
expression is not affected by Rbpj-deﬁciency (Fig. 4A and
4B), suggesting that RBP-J is dispensable for IL-4 signaling
and STAT6 activation in macrophages. In addition, C/EBPβ
protein expression was unchanged in Rbpj-deﬁcient mac-
rophages (data not shown), implying that neither STAT6 nor
C/EBPβ is the target of RBP-J-mediated regulation.
Recently, the transcription factor, interferon regulatory factor
(IRF) 8, has also been implicated in regulating Arg1
expression under various experimental conditions (Pourcet
et al., 2011). We found that both at baseline and following
IL-4 stimulation, IRF8 protein expression did not signiﬁcantly
differ between WT and Rbpj-deﬁcient macrophages
(Fig. 5B), suggesting that IRF8 expression is not regulated
by RBP-J under these experimental conditions. Furthermore,
BMDMs from Irf8-null mice showed normal expression and
induction of Arg1 mRNA (Fig. 5C) and protein (Fig. 5D) fol-
lowing IL-4 stimulation, conﬁrming that IRF8 is dispensable
for IL-4-induced expression of Arg1 in macrophages. Taken
together, our results indicate that RBP-J determines basal
macrophage Arg1 expression but does regulate transcription
factors such as STAT6, C/EBPβ, and IRF8 that induce Arg1
expression in response to environmental cues.
DISCUSSION
In this study we demonstrated that functional polarization of
M2 macrophages in vitro and in vivo is critically regulated by
a transcription factor RBP-J that integrates signals from
multiple input sources including the Notch signaling pathway.
RBP-J expression in myeloid cells promoted M2-mediated
immune effector functions including recruitment of eosino-
phils and suppression of T cell proliferation by regulating
expression of a subset of M2-associated genes. Our results
identiﬁed RBP-J as a key regulator of M2 polarization and
suggest that targeting pathways that modulate RBP-J
activities has the potential of altering macrophage polariza-
tion processes and subsequent immune effector responses.
One notable feature of regulation of the M2 gene program
by RBP-J is its selectivity. In contrast to many previously
described M2-driving transcription factors such as IRF4 and
Stat6 that promote expression of a wide-range of M2-asso-
ciated genes, RBP-J only selectively enhances expression
of a subset of M2 genes including those encoding Arg1 and
MR while imposing minimal or even inhibitory effects on
other well-characterized M2 signature genes. The highly
selective nature of RBP-J on the M2 gene program is remi-
niscent of its role in M1 polarization, in which only a subset of
M1 signature genes are regulated by RBP-J. Thus, it
emerges that instead of a so-called “master transcription
regulator” by a conventional deﬁnition, RBP-J serves to
focus the macrophage responses on certain modules
appropriate for the current microenvironment and cellular
context. For example, within the broad range of various M1
effector functions, RBP-J predominantly focuses on the
“bacterial host defense” module by targeting IL-12 and iNOS
with minimal impact on “acute inﬂammation” module by
sparing IL-1β. Similarly, under M2 polarizing conditions,
RBP-J mainly controls eosinophil recruitment and T cell
responses by targeting Arg1 while leaving Stat6-dependent
processes mostly untouched. Given the highly speciﬁc and
focused nature of RBP-J-mediated regulation and the fact
that RBP-J integrates signals from diverse environmental
cues, we propose to conceptualize RBP-J as a modular
regulator of M1-M2 macrophage polarization processes
whose activities can be ﬁne-tuned in a context-dependent
manner.
Given the fact that RBP-J promotes certain components
of canonical M1 as well as M2 responses, it is anticipated
that RBP-J would possess complex and context-dependent
biological functions in vivo that could not be attributed as
simply promoting or suppressing inﬂammatory and immune
responses. Indeed, this is often the case. While we and
others have shown that RBP-J is essential for host defense
against certain intracellular bacterial species, expression of
RBP-J in tumor-associated macrophages (TAMs) is sup-
pressive for T-cell mediated anti-tumor immune responses
(Franklin et al., 2014). This notion is in line with our obser-
vations that RBP-J in macrophages is required for inhibition
of T cell proliferation under both ex vivo and in vitro M2-
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polarizing conditions (Fig. 3A and 3B) and suggests that
antagonizing RBP-J activities in TAMs may represent a
novel strategy of anti-tumor immune-therapy via boosting T
cell responses.
In addition to biological consequences of RBP-J-medi-
ated regulation, we also sought to investigate molecular
mechanisms by which RBP-J regulated M2 gene expression
especially expression of Arg1 given its role as a critical M2
effector molecule and its drastic regulation by RBP-J at the
protein level (Fig. 4A). RBP-J appeared to maintain consti-
tutive Arg1 expression in macrophages without signiﬁcantly
altering the capacity of macrophages to upregulating Arg1
expression in response to stimuli such as IL-4. These
observations raised several interesting questions regarding
mechanisms of Arg1 regulation. Firstly, is Arg1 a direct
Notch target gene or is its expression regulated by RBP-J via
indirect means? These two possibilities can be distin-
guished by application of the Notch signaling inhibitors such
as γ-secretase inhibitors or usage of Notch component-
deﬁcient animals in the future experiments. Secondly, the
result that RBP-J did not regulate IL-4-activated Stat6 sig-
naling suggests that regulation of Arg1 is Stat6-independent.
Indeed, consistent with this notion, IL-4-Stat6 signaling is
also dispensable for M2 effector functions in the chitin-in-
duced model (Reese et al., 2007). Previous reports have
shown that leukotriene B4 and its high-afﬁnity receptor BLT1
are essential for chitin-induced M2 polarization (Reese et al.,
2007) and it will be of great interest to investigate the
involvement of leukotriene in RBP-J-mediated regulation of
M2 phenotypes in the future.
MATERIALS AND METHODS
Mice
Rbpjﬂox/ﬂox mice were kindly provided by Tasuku Honjo. Mice with a
myeloid-speciﬁc deletion of Rbpj were generated by crossing
Rbpjﬂox/ﬂox animals to animals with a Lyz2-Cre on the C57/BL6
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Figure 5. RBP-J regulates Arg1 expression in macrophages independently of STAT6 and IRF8. (A) BMDMs from WTand Rbpj
cKO mice were stimulated with 100 ng/mL of IL-4 for the indicated times. Whole cell lysates were analyzed with immunoblotting using
antibodies recognizing STAT6 phosphorylated on Tyr641 (pSTAT6). Levels of SHP2 served as loading controls. Results are
representative of three independent experiments. (B) BMDMs from WTand Rbpj cKO mice were stimulated with 10 ng/mL of IL-4 and
1 ng/mL of LPS for the indicated times. Whole cell lysates were analyzed with immunoblotting using antibody recognizing IRF8.
Levels of p38 served as loading controls. Results are representative of three independent experiments. (C) mRNA expression of Arg1
(relative to GAPDH mRNA) was measured in BMDMs from WT and Irf8−/− mice. Cumulative results from two independent
experiments (errors bars indicate s.d.) are shown. (D) BMDMs from WTand Irf8−/− mice were stimulated with 10 ng/mL of IL-4 for the
indicated times. Whole cell lysates were analyzed with immunoblotting using antibodies against Arg1 and IRF8. Levels of SHP2
served as loading controls. Results are representative of three independent experiments.
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Rbpjﬂox/ﬂoxLyz2-Cre genotypes were used for experiments. Gender-
matched littermates with Rbpj+/+Lyz2-Cre or Rbpjﬂox/+Lyz2-Cre
genotypes were used as controls. OT-II transgenic mice were
obtained from the Jackson Laboratory. The experiments using mice
were approved by the Hospital for Special Surgery and Tsinghua
University Institutional Animal Care and Use Committees.
Chitin administration
Chitin was obtained from Sigma, washed three times in PBS, and
sonicated on ice. The suspended solution was ﬁltered through a
100 μmol/L strainer and diluted in 50 mL PBS. Approximately 800 ng
of chitin was intraperitoneally injected to each mouse and peritoneal
exudate cells (PECs) were collected 1 d after chitin injection for ﬂow
cytometry and gene expression analysis.
Flow cytometry
PECs were harvested and stained with antibodies speciﬁc to F4/80,
CD11b, CD45, and/or SiglecF (BD). Cells were then washed three
times with ﬂow cytometry buffer. Data was acquired on a FACScan
ﬂow cytometer (BD) and analyzed using Cell Quest software (BD).
Cells and reagents
Murine BMDMs were obtained as described and maintained in
DMEM supplemented with 10% FBS and 10% L929 cell supernatant
as conditioned medium providing macrophage colony stimulating
factor (M-CSF). After 5 days of culture, ﬂoating cells were discarded
and attached macrophages were re-plated in 12-well plates over-
night prior to stimulation. Recombinant mouse IL-4 was from
Peprotech and used at 10 ng/mL unless otherwise noted.
mRNA isolation and real time PCR
RNA was extracted from whole cell lysates with an RNeasy Mini kit
(Qiagen) and 0.5 μg of total RNA was reverse transcribed with a
First Strand cDNA synthesis kit (Fermentas). Quantitative real time
PCR (qRT-PCR) was performed in triplicate wells with an iCycler IQ
thermal cycler and detection system (Biorad) using gene-speciﬁc
primers. Threshold cycle numbers were normalized to triplicate
samples ampliﬁed with primers speciﬁc for of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH).
Proliferation assay
CFSE-labeled OT-II transgenic LN cells were co-cultured with PECs
or BMDMs from WT or Rbpj-deﬁcient mice and cognate OVA pep-
tide. Proliferation of CD4+ cells was examined at 96 h of co-culture
by assessing CFSE dilution using ﬂow cytometry.
Immunoblotting analysis
Whole cell lysates were prepared by direct lysis in SDS loading
buffer. For immunoblot analysis, lysates were separated by 7.5%
SDS-PAGE and transferred to a PVDF membrane for probing with
antibody. Polyclonal antibodies against arginase 1, IRF8, p38, and
Shp2 were from Santa Cruz Biotechnology. pY-Stat6 antibody was
from Cell Signaling Technology.
Statistical analysis
All statistical analyses were performed by using the Student’s t test.
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